Sabine Yerly - Concepedia

Author

Sabine Yerly

Also Known As

A. de Rougemont, Ania Wisniak, Christoph Niederhauser, Cyril Shah, Fort de G Dos Santos, G Dos Santos, G Wandeler, G. Wandeler, Géraldine Poulain, H. Barth

452

Publications

19.7K

Citations

H-Index

103

Concepts

All Affiliations

University Hospital of Geneva University Hospital of Zurich University of Zurich University of Basel University of Lausanne

About

Sabine Yerly is an author at University Hospital of Geneva specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	59	4.9K
2	Public Health	16	21	1.7K
3	Engineering	1	1	12
4	Natural Sciences	1	1	102
5	Allergy	1	1	12

Sabine Yerly

194

Publications

14.3K

Citations

H-Index

Page 1

	Year	Citations
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, The Lancet	2020	1.1K
Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management Annemarie M. J. Wensing, David van de Vijver, Gioacchino Angarano, The Journal of Infectious Diseases	2005	420
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser, New England Journal of Medicine	2015	404
Transmission of antiretroviral-drug-resistant HIV-1 variants Sabine Yerly, Laurent Kaiser, Esther Race, The Lancet Human RetrovirusImmunologyAntiviral TherapyResistance Mutation (Virology)Virology	1999	397
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen Nicolas Sachsenberg, Alan S. Perelson, Sabine Yerly, The Journal of Experimental Medicine	1998	331
The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan Victor DeGruttola, Lynn P. Dix, Richard T. D’Aquila, Antiviral Therapy PharmacotherapyAntiviral DrugDrug ResistanceProspective StudiesHuman Retrovirus	2000	330
A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection Sabine Kinloch de Loes, Bernard Hirschel, Bruno Hoen, New England Journal of Medicine	1995	312
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial Angela Huttner, Julie-Anne Dayer, Sabine Yerly, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyPreventive MedicineImmunology	2015	276
Estimating the Basic Reproductive Number from Viral Sequence Data Tanja Stadler, Roger D. Kouyos, Viktor von Wyl, Molecular Biology and Evolution Virus EpidemiologyGeneticsGenetic EpidemiologyViral DynamicEpidemiological Dynamic	2011	270
A Patient with HIV-1 Superinfection Stéphanie Jost, Marie‐Charlotte Bernard, Laurent Kaiser, New England Journal of Medicine Primary ImmunodeficiencyVaccinationVaccine Research ProtocolHuman RetrovirusImmunology	2002	245

Page 1